Credit Rating 14 Oct - CARE assigned issuer rating CARE BBB; Stable to Creative Graphics Solutions India Limited.
Source: Nse
Industrials stocks · SME cap · NSE
Creative Graphics Solutions India Ltd. processes digital & analogue plates for flexography, letter press, corrugated box printing & U.V. spot coating. Its Wahren subsidiary manufactures pharma packaging products like Alu Alu, Blister, PVC, and PVDC foils, serving a wide client base across India and targeting exports.
SMA20 +2.3% / mo · MACD −
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +102.4% · PAT +75.0% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +102% YoY · PAT +75% YoY · margin compression
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹170 Cr | +102.4% | -3.4% |
| EBITDA | ₹12 Cr | NDF | -42.9% |
| Operating margin | 7.0% | NDF | -500 bps |
| PAT | ₹7 Cr | +75.0% | -41.7% |
| PAT margin | 4.1% | NDF | -270 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 21/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term trend down. RSI 42.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 50 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
FY26 consolidated income grew to Rs.348 crores from Rs.135 crores in FY24, but net profit after tax declined to Rs.18.67 crores from Rs.20.77 crores in FY25. H2 FY26 saw significant profit decline due to front-loaded expansion costs and raw material price volatility.
Profitability is under stress due to front-loaded expansion costs, raw material price volatility (aluminum, PVC, Nylon), and war-related supply chain disruptions. While capacity is being built for future growth, current execution is hampered by procurement challenges and project delays, impacting H2 FY26 results significantly.
Latest issuer-disclosed distribution across 2 reported categories.
PVC, PVDC product line commercialized; new tandem machine commercialized in April, offering a different product line for pharma companies.
Received first export order in February, now has 100+ metric tons of export orders, targeting better realization and profit/margin contribution.
New 20,000 metric ton Alu Alu factory is installed and on the cusp of commercialization, capable of supporting Rs.1000+ crores turnover.
Anticipates a much better year for flexographic printing plates due to EPR practices coming into picture.
Bangalore facility commercialized, currently in the stage of acquiring clients and testing.
Oman expansion delayed due to war issues, supply challenges, and manpower; hopes to commercialize in the coming quarter.
Production of PVC, PVDC machine commercialized, currently facing some raw material shortage.
Bosch machine (Alu Alu factory) installed, trials ongoing, commercial revenues expected 'very soon' (next month).
No impact on the demand side for pharma packaging; order book is full.
Received 30%+ price hikes on pharma products (e.g., from Rs.400 to Rs.550) to offset raw material cost increases.
Tied up with Citibank for Rs.60 crores limit and initiated bill discounting transactions (Rs.3-4 crores in March), which are scalable.
Anticipates that EPR practices will lead to a much better year for flexographic printing plate sales.
H2 was volatile due to 'tantrums from America' and war-related supply chain issues, impacting aluminum, PVC, and Nylon derivative prices.
Severe delays in raw material imports, cancellation of orders from suppliers, and restricted supply in March, continuing in April and May.
Bosch machine (Alu Alu factory) got delayed; Oman expansion delayed due to war issues.
Clogging at all ports and rail is taking a lot of time, impacting raw material clearing and availability.
Supply chain issues are not 'out of the woods yet'; world continues to remain volatile, impacting raw material availability.
Volatility in aluminum and other commodity prices will continue to impact the business, though the company aims to be better prepared.
Increased working capital requirements due to higher raw material prices and expanded operations need continuous management.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is relevant for assessing overall growth trajectory and full-year performance. QoQ (H1 vs H2) is crucial to understand the immediate impact of supply chain issues, raw material volatility, and project delays on sequential momentum and profitability.
Total consolidated income for the year was Rs.348 crores, up from Rs.135 crores in FY23-24.
Net profit after tax was Rs.18.67 crores in FY25-26, down from Rs.20.77 crores in FY24-25.
H2 2026 revenue was Rs.172 crores, a slight drop from H1 2026 (Rs.177 crores) but up significantly YoY from H2 2025 (Rs.140 crores).
Profit at consolidated level declined to Rs.6.55 crores from Rs.12.21 crores in H1 2026 and significantly declined compared to H2 2025.
Expects some volatility in H1 FY27 but is very optimistic for H2, assuming normalization within a month to a month and a half.
Maintains ambition to double top line every year, believing installed capacity can support Rs.1000+ crores turnover, acknowledging non-linear growth.
Taking steps to fill coffers with supplies and be fully prepared in the coming months to mitigate future supply problems.
Currently holds 8-10% market share in Alu Alu and is looking to have better capitalization in the coming year.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Raw Material Supply Normalization | Still not out of the woods yet, but visibility on things normalizing. | Consistent and timely raw material procurement, reduced delays at ports and in transit. |
| New 20,000 MT Alu Alu Factory Commercialization | Installed, trials ongoing, on the cusp of starting commercial revenues (expected next month). | Official announcement of commercial operations and ramp-up of production. |
| PVC/PVDC Plant Utilization | Very small revenue recognized, targeting 25% utilization for FY27. | Sequential increase in PVDC revenue and progress towards targeted utilization. |
| Flexo Business Ramp-up (Bangalore & Oman) | Bangalore commercialized, in client acquisition. Oman delayed, expected next quarter. | Successful client acquisition in Bangalore and commercialization of the Oman facility. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 22nd percentile of the scored universe and 18th percentile within Industrials. Main check: cash conversion is weak at 28/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Industrials: 18th pctile, median 68 · SME: 24th pctile, median 64
12 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Company Ir
Source: Nse